Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2010 / Cilt: 44 - Sayı: 4

Coexistence of metabolic syndrome and psoriasis vulgaris

Psoriasisli hastalarda metabolik sendrom birlikteliği

Pages
204–208
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We found that the mean value of triglyceride levels was statistically higher in the psoriasis group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Psoriasis is one of the chronic inflammatory systemic diseases, such as rheumatoid arthritis, systemic lupus erythematosus and Crohn's disease, in which the inflammation is responsible for the pathogenesis.
📊
Key Findings & Data:A PASI score below 7 was accepted as mild, between 7-12 as moderate, and above 12 as severe.
💡
Conclusion & Impact:We found that the mean value of triglyceride levels was statistically higher in the psoriasis group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Design: Psoriasis is one of the chronic inflammatory systemic diseases, such as rheumatoid arthritis, systemic lupus erythematosus and Crohn's disease, in which the inflammation is responsible for the pathogenesis. Recently, some studies reported the importance of chronic inflammation in the pathogenesis of atherosclerosis and an association of chronic inflammatory systemic diseases with atherosclerosis and metabolic syndrome. The aim of this study is to determine coexistence of psoriasis vulgaris with various severity and metabolic syndrome. Material and Method: One hundred psoriasis vulgaris patients and one hundred sex- and age-matched healthy controls were included in this study. The Psoriasis Area and Severity Index (PASI) was used for evaluating the disease severity in psoriasis patients. A PASI score below 7 was accepted as mild, between 7-12 as moderate, and above 12 as severe. We evaluated metabolic syndrome in both patient and control groups by using the Adult Treatment Panel III (ATP III) metabolic syndrome criteria. SPSS 10.0 for Windows was used in analyzing data. For comparison, the student’s-t test, the Mann-Whitney U test and the chi-square test were used. A p-value less than 0.05 was considered statistically significant. Results: Metabolic syndrome, hypertension, elevated fasting plasma glucose and triglyceride levels, high waist circumference and lower high-density lipoprotein levels were more common in patients with psoriasis than in controls. However, there was no statistically significant difference in these parameters between these two groups (p>0.05). We found that the mean value of triglyceride levels was statistically higher in the psoriasis group (p

Özet

Amaç: Psoriasis; romatoid artrit, sistemik lupus eritematozus, Crohn hastalığı gibi patogenezinde inflamasyonun rol oynadığı kronik inflamatuvar sistemik hastalıklar grubunda yer almaktadır. Son zamanlarda kronik inflamasyonun ateroskleroz patogenezinde önemine ve kronik inflamatuvar hastalıklar ile ateroskleroz-metabolik sendrom birlikteliğine değinen çalışmalar bulunmaktadır. Bu çalışmanın amacı değişik şiddetteki psoriasis vulgarisli hastalarda metabolik sendrom birlikteliğini araştırmaktı. Gereç ve Yöntem: Çalışmaya 100 psoriasis vulgarisli hasta, yaş ve cinsiyeti hasta grubuyla uyumlu 100 sağlıklı kontrol alındı. Psoriasisli hastalarda hastalığın şiddetinin değerlendirilmesinde PAŞİ kullanıldı. PAŞİ değeri 7’nin altında olanlar hafif, 7-12 arası orta ve 12’nin üzerinde olanlar şiddetli olarak kabul edildi. Hasta ve kontrol grubunda ATP III metabolik sendrom kriterleri kullanılarak metabolik sendrom araştırıldı. Verilerin değerlendirilmesinde SPSS for windows 10.0 istatistik paket programı kullanıldı. Karşılaştırmalarda student’s t, Mann Whitney U, ki-kare testleri kullanıldı. p0,05). Psoriasis grubunun ortalama trigliserid düzeyi kontrol grubuna göre istatistiksel olarak anlamlı derecede daha yüksek saptandı (p

🔖

Cite This Article

BALABAN, D., ÇELİK, R., DERVİŞ, E., CAN, G. (2022). Coexistence of metabolic syndrome and psoriasis vulgaris. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 44 - Sayı: 4, 204–208. https://ajindex.com/articles/622019

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Späh F: Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol 2008;159:10-7
  2. Gülekon A, Adışen E: Psoriasis ve komorbiditeler. Türkderm 2008;42;2:23-5
  3. Scott M. Grundy: Metabolic syndrome: A growing clinical challenge. Medscape Cardiology 8(2), 2004
  4. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607
  5. Al Lawati JA, Jousilahti PJ: Prevalence and 10-year secular trend of obesity in oman. Saudi Med J 2004;25:346-51
  6. De Bacquer D, De Backer G, Cokkinos D et al: Overweight and obesity in patients with established coronary heart disease: are we meeting the challenge? Eur Heart J 2004;25:121-8
  7. Gutierrez-Fisac JL, Lopez E, Banegas JR, Graciani A, Rodriguez-Artalejo F: Prevalence of overweight and obesity in elderly people in Spain. Obes Res 2004;12:710-5
  8. Matsushita Y, Yoshiike N, Kaneda F, Yoshita K, Takimato H: Trends in childhood obesity in Japan over the last 25 years from the national nutrition survey. Obe Res 2004;12:205-14
  9. Yoshinaga M, Shimago A, Koriyama C et al: Rapid increase in the prevalence of obesity in elementary school children. Int J Obes Relat Metab Disord 2004;28:494-9
  10. Rami B, Schober E, Kirchengast S, Waldhor T, Sefranek R: Prevalence of overweight and obesity in male adolescents in Austria between 1985 and 2000. A population based study. J Pediatr Endocrinol Metab 2004;17:67-72
  11. Rio-Navarro BE, Velazquez-Monroy O, Sanchez-Csatillo CP et al: The high prevalence of overweight and obesity in Mexican children. Obes Res 2004;12:215-23
  12. Mallbris L, Granath F, Hamsten A, Stahle M: Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 2006;54:2-13
  13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
  14. Grundy SM, Brewer HB Jr, Cleeman JI et al: Definition of Metabolic Syndrome: Report of The National Heart, Lung and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004;109:433-8
  15. Cohen AD, Gilutz H, Henkin Y et al: Psoriasis and the metabolic syndrome. Acta Derm Venereol 200